{"nct_id":"NCT02704403","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)","status":"TERMINATED","status_verified_date":"2022-02","start_date":"2016-03","start_date_type":null,"primary_completion_date":"2020-10-28","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GNFT"]}